Ingredion Inc. (INGR)
Ingredion's Clean-Label Demand Rises: Can Share Gains Keep Building?
Ingredion's clean-label demand fuels T&HS volume growth and share gains, though rising tapioca costs may pressure near-term benefits.
Can Ingredion's T&HS Solutions Sustain Growth Momentum in 2026?
Ingredion's T&HS growth is powered by clean-label, texture and nutrition demand, with 2026 sales and profit still expected to rise despite cost pressures.
Ingredion's Mexico Headwinds Persist: Can LATAM Profitability Recover?
Ingredion's LATAM sales rise in Q2, but softer Mexico demand and currency effects hurt margins, with 2026 operating income expected to decline.
Ingredion Incorporated (INGR) Presents at Barclays 19th Annual Global Consumer Staples Conference Transcript
Ingredion Incorporated (INGR) Presents at Barclays 19th Annual Global Consumer Staples Conference Transcript
Ingredion Q2 Earnings Beat Estimates on T&HS Volume Growth
Ingredion beats Q2 estimates as 7% Texture & Healthful Solutions volume growth and FX gains offset Argo issues and higher costs.
Ingredion Q2 Earnings Call Highlights
Ingredion NYSE: INGR reported second-quarter 2026 results that were in line with its expectations, as continued growth in Texture & Healthful Solutions offset operational and macroeconomic pressures in other parts of the portfolio.
Ingredion Incorporated (INGR) Q2 2026 Earnings Call Transcript
Ingredion Incorporated (INGR) Q2 2026 Earnings Call Transcript
Ingredion (INGR) Q2 Earnings and Revenues Beat Estimates
Ingredion (INGR) came out with quarterly earnings of $2.82 per share, beating the Zacks Consensus Estimate of $2.73 per share. This compares to earnings of $2.87 per share a year ago.
Is Ingredion Stock a Buy as Cheap Valuation Meets Execution Risk?
Ingredion's cheap valuation and growing specialty business support the bull case, but Argo execution risks and weaker guidance argue for patience.
How Ingredion's Tate & Lyle Deal Could Reshape Its Growth Outlook
Ingredion's proposed $5 billion Tate & Lyle deal could expand its specialty platform and global reach, but approvals and integration risks remain.
Analysts Estimate Ingredion (INGR) to Report a Decline in Earnings: What to Look Out for
Ingredion (INGR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Ingredion to Take Over Tate & Lyle in $3.6 Billion Deal
Ingredion offered the equivalent of $7.94 for each Tate & Lyle share, a 59% premium to the last closing price before takeover talks were disclosed last month.
